Axsome Therapeutics Amends Silicon Valley Bank Loan Agreement Increasing Financial Flexibility

NEXT STORY
Unum Therapeutics Announces New Appointments to its Board of Directors
PREV STORY
GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Loxo Oncology to Announce First Quarter 2017 Financial Results

STAMFORD, Conn., May 02, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive ...

author_avatar
NASDAQ Market News

Immunotherapy Drugs Market Size to Reach $227.6 Billion by 2023: P&S Intelligence

Immunotherapy Drugs Market by Type (Checkpoint Inhibitors [Brand {Humira, Rituxan/MabThera, Herceptin, Remicade, Enbrel}], Vaccines ...

author_avatar
NASDAQ Market News